Georges Gemayel, Ph.D.

Georges Gemayel, Ph.D.

DirectoratSupernus Pharmaceuticals· In proxies 2023–2025

Georges Gemayel, Ph.D. sits on 11 public boards.

Boards1

  • Supernus PharmaceuticalsDirector · 10 yr on the boardIndependentCEO and Compensation (Chair), Directors and Audit, Governance and Nominating, Science—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Supernus PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +12%
  2. Disc Medicine Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Enterome Bioscience SAPublic company
    • Director? – PresentNo stock prices for these years
  4. GlycoEra AGPublic company
    • Director? – PresentNo stock prices for these years
  5. Adolor CorporationPublic company
    • Director? – PresentNo stock prices for these years
  6. Dimension TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  7. Flamingo TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  8. Momenta PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  9. NPSPublic company
    • Director? – PresentNo stock prices for these years
  10. ProsensaPublic company
    • Director? – PresentNo stock prices for these years
  11. Raptor Pharmaceutical Corp.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?